Clinical Trials Logo

Cardiopulmonary clinical trials

View clinical trials related to Cardiopulmonary.

Filter by:

NCT ID: NCT06092827 Not yet recruiting - Physical Inactivity Clinical Trials

Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration

DB-ACTIV
Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.

NCT ID: NCT06060145 Not yet recruiting - Cardiopulmonary Clinical Trials

Effect of Indoor Plants on Cardiopulmonary System

Start date: October 16, 2023
Phase: N/A
Study type: Interventional

This is a randomized controlled human exposure crossover study, aims to explore the health benefits of indoor plants on cardiopulmonary system on adults.

NCT ID: NCT05869747 Recruiting - Exposure Clinical Trials

Firefighter Collaborative Research Project

FCRP
Start date: June 22, 2023
Phase: N/A
Study type: Interventional

The goal of this research is to test interventions to reduce firefighter cardiovascular, cognitive, and overall disease risks, including but not limited to risks associated with Per- and Polyfluorinated Substances (PFAS) exposure. Approximately 1,500 - 2,000 firefighters will be enrolled in the Fire Fighter Cancer Cohort Study (FFCCS). Among these individuals, those that express interest will then be screened for eligibility for the Firefighter Collaborative Research Project (FCRP) using information they provided for the Fire Fighter Cancer Cohort Study. Firefighters enrolled in the study will provide an initial blood sample and urine sample. The blood sample will be analyzed to determine the participant's PFAS levels. Based upon serum PFAS levels and responses from the screening survey, eligible participants will be randomly assigned into one of the following interventions: 1. Blood Donation, or Plasma Donation or Blood/Plasma Control Group; 2. Zone 2 Training or Zone 2 Control; 3. Intermittent Fasting or Intermittent Fasting Control. Individuals participating in the blood donation, plasma donation or blood/plasma control group would donate blood every 12 weeks, plasma every 6 weeks, or not donate blood or plasma. Participants in this intervention arm would continue this for a 12-month period. Individuals in the zone 2 training, zone 2 training control, intermittent fasting or intermittent fasting control group would participate in their intervention or control for a 4-month period. After 4 to 12 months participating in an intervention or control group, participants will be asked to provide a final urine sample and blood draw to determine if and to what degree their PFAS levels or other cardiovascular disease and other health risks have changed.

NCT ID: NCT05787353 Completed - Cardiopulmonary Clinical Trials

Cardiopulmonary Rehabilitation for Post-acute COVID-19 Symptoms

Start date: April 16, 2021
Phase: N/A
Study type: Interventional

The purpose of this RETROSPECTIVE study was to compare the effect of a hospital and home-based cardiopulmonary rehabilitation (CPR) program on exercise endurance and quality of life in post-acute COVID-19 patients. 88 post-acute COVID-19 patients were divided two groups according to receiving hospital (n=45) or home-based CPR (n=43)in our rehabilitation clinic between January and July 2021. Both protocols consisted of aerobic, breathing and flexibility exercises. Hospital-based CPR: three or four days per week for a total of 20 sessions. Home-based CPR: three or four days/a week over a period of six weeks. The results of six meters walk test (6MWT) for exercise endurance as a main outcome measure, and Borg-dyspnea/fatigue, the visual analog scale (VAS) for pain and the Short Form-36 (SF-36) as secondary outcome measures before and after treatment were recorded.

NCT ID: NCT05678530 Recruiting - Cardiopulmonary Clinical Trials

Estimated VO2Max Validation

Start date: June 6, 2019
Phase:
Study type: Observational

In this study, the hypothesis being explored is that VO2Max and other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using wearable biosensors worn by study participants. This study will aim to collect development and validation data for a machine learning algorithm and to evaluate the performance of the algorithm. A total of 300 participants will be enrolled including: (Normal) 200 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 100 participants

NCT ID: NCT05518136 Completed - Infant Development Clinical Trials

Evaluations of Cardiopulmonary Function and Motor Development of Congenital Heart Disease

Start date: April 10, 2021
Phase: N/A
Study type: Interventional

In this single-center, randomized controlled trial, patients (4-8 months) with CHD were randomly assigned to either a recovery group (home-based rehab exercise periodically) supervised by cellphone APP or to a control group. Left ventricular ejection fractions (LVEF), the rate of increase in heart rate (rHRI), and the rate of recovery heart rate (rHRR) were measured for representing cardiopulmonary capacity. The Alberta test and Neuro-intelligence Scale were used to evaluate their motor developmental outcomes. This study verified the feasibility of this rehab method and indicated that 6-month home-based exercise training can improve cardiopulmonary endurance and motor developmental level in infant CHD patients.

NCT ID: NCT05145192 Recruiting - Exercise Clinical Trials

COSMED K5 Validation and Reliability Study

K5
Start date: November 29, 2021
Phase: N/A
Study type: Interventional

To determine the validity of the K5 metabolic system breath-by-breath analysis setting during a high intensity treadmill running protocol compared to the criterion ParvoMedics TrueOne® 2400 automated metabolic gas analysis system. To determine the test-retest reliability of the K5 metabolic system breath-by-breath analyzer during a high intensity treadmill protocol (Bruce Protocol).

NCT ID: NCT04833010 Active, not recruiting - Covid19 Clinical Trials

Effects of Face Masks During Exercise

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

To describe the primary and secondary outcomes of athletes during a Cardiopulmonary Exercise Test (CPET) on a cycle ergometer with and without a face mask.

NCT ID: NCT03123536 Recruiting - Ultrasonography Clinical Trials

Use of Point-of-care Ultrasound in High Risk Surgical Patients

Start date: February 1, 2017
Phase: N/A
Study type: Observational

There is currently a lack of evidence to support the use of perioperative point-of-care ultrasound to assess the outcomes in high risk surgical patients. Thus, the purposes of this study were to evaluate whether perioperative use of point-of-care ultrasound can reduce the worse postoperative outcomes in high surgical patients.

NCT ID: NCT02286297 Recruiting - Pediatric Clinical Trials

Pediatric Endotracheal Intubation During Resuscitation

PETI
Start date: November 2014
Phase: N/A
Study type: Interventional

Endotracheal intubation (ETI) is perceived as the optimal method of providing and maintaining a clear and secure airway. The 2010 European Resuscitation Council (ERC) guidelines emphasized the importance of minimal interruption during cardiopulmonary resuscitation (CPR). These guidelines also suggest that skilled operators should be able to secure the airway without interrupting chest compression. The aim of the study was to compare time and success rates of different available video laryngoscopes and the Miller laryngoscope for emergency intubation during simulated pediatric CPR.